2020-03-30 Product Development Considerations for Vials and Pre-Filled Syringes by Allison A. Cacciatore
Filter by
2020-03-25 CONNECT: PSG’s Virtual Networking Event & Evening Seminar
2020-03-23 Digitalization and Industry 4.0 – How to Increase Productivity and Compliance in Pharmaceutical Processes by Rodrigo Correa
2020-04-09 How To Adjust Your GMP Facility Amid Covid-19 by Jeff Hartry
2020-04-22 Legal Pandemic Insights by Maria Kotsopoulos & Christopher McClelland
2020-04-16 How To Relax In Difficult Times by Dr. Alireza Sharifi
2020-11-04 COVID 19 From a Toxicologist’s Perspective by Dr. Wendy Haines
2020-10-28 Managing Compliance Outcomes in the Virtual World by Aaron Clarke
2020.09.22 How to Conduct a Remote Audit by Jane Weitzel
2020.08.25 Medical Device Online Conference 6 – Q&A Panel Discussion
2020.08.25 Medical Device Online Conference 5 – Telemedicine and AI for Medical Devices by Robin Osmond
2020.08.25 Medical Device Online Conference 4 – US FDA Statistical Requirements & Considerations for Medical Devices by Joanne Lin
2020.08.25 Medical Device Online Conference 3 – Quality Management Approach to Health Canada’s Interim Orders on Medical Devices by Frederic Hamelin
2020.08.25 Medical Device Online Conference 2 – Forces & Trends in Medical Device Innovation by Sheryl Thingvold
2020.08.25 Medical Device Online Conference -Real World Evidence for Medical Devices by Robbert Zusterzeel
2020 PSG Inspector Powers Interactive Online Seminar
2020 – A Day with the Inspectors – Interactive Panel Discussion with Health Canada Inspectors
2020 – A Day with the Inspectors – Updates on GMP Guidance Documents by Farzana Saadat
2020 – A Day with the Inspectors – Inspections Trends & General Updates (Including Cost Recovery by Joy Bregg
2020 – A Day with the Inspectors – Virtual Inspections & Remote GMP Evaluations by Maria Teresa Forlini & Melanie Bhangoo
2020 – A Day with the Inspectors – Applying Quality Risk Management Principles to Ensure GMP Compliance during Covid 19 by Anthony Lostracco
2020-06-15 Good Documentation Practices by Josephine Wray
2020-06-10 Health Canada & FDA Current Sanitation Regulations For The Medical Cannabis Sector by Peivand Pirouzi
2020-05-19 Health Canada & FDA Regulations For Cannabis Facility Management & Security by Peivand Pirouzi
2019 Fall Conference — Key Differences: Health Canada GPP and European EU-GMP Export Expectations by Aaron Clarke
2019 Fall Conference — Energy Reduction Strategies for Cannabis Operations by Michael Voll
2019 Fall Conference — GPP Testing Requirements for Cannabis in its Different Dosage Forms by Elfi Daniel-Ivad
2019 Fall Conference — Challenges and Opportunities of IP in the Cannabis Industry by Nicholas Wong & Junyi Chen
2019 Fall Conference — Fireside Chat with Shane Morris & Kym Purchase: All policies considered, will Canada maintain its position as leaders of the global cannabis industry?
2019 Fall Conference — Preserving M&A value through Effective Integration by Giselle Commissiong
2019 Fall Conference — Know, To Grow – Insight on the Current State of the International Market by Karen Debroni & Dr. Shelley Turner
2019 Fall Conference — Health Research and Clinical Trials with Cannabis by Paul Smeaton
2019 Fall Conference — Vigilance of Cannabis Products in Canada by Stephanie Jack
2019 Fall Conference –A HC Cannabis Inspection and the Amended Cannabis Regulations by Kourtney Adams & Mirjana Pilipovic
2019 Fall Conference –Research Licensing under the Cannabis Act and Cannabis Regulations by Mike McGuire
2019 Fall Conference –Cannabinoids A Viewpoint Influenced by Impressionist Art by Dr. Jake Thiessen
2019-10-23 *WEBINAR* Serialization : Overview of Planning & Execution
2019.02.27 PSG_Medical Devices — Business Tools for Bringing your Device to Market by Dr. Chaitanya Baliga
2019.02.27 PSG_Medical Devices — Medical Devices Global Harmonization Efforts by Marcela Saad
2019.02.27 PSG_Medical Devices — Engaging with the FDA: An Insider’s Perspective by Dr. Yuan Fang
2019.02.27 PSG_Medical Devices — Current State & Health Canada Expectations of the MDSAP by Frederic Hamelin
2019 – Pharmacovigilance EXPO — Reporting Foreign Safety Actions to Health Canada by Bruce Wozny
2019 – Pharmacovigilance EXPO – An Overview of Pharmacovigilance in Canada by Agnes Jankowicz
2019 – A Day with the Inspectors — Panel Discussion
2019 – A Day with the Inspectors– Health Canada Guidance Update & Case Studies by Anthony Lostracco
2019 – A Day with the Inspectors– GMP Evidence for Foreign Building Risk Issues & Assessments by Ann Kourtesis
2019 – A Day with the Inspectors– DELU Updates by Marc-Andre Labelle
2019 – A Day with the Inspectors –Overview & Updates from the Health Products Inspection & Licensing (HPIL) Division by Kimby Barton
Qualifications _ Use Of Contract Sterilization Services
CSV – Considerations for Data Integrity
2018 Breakfast with the Inspectors – DEL Processing by Mary Morgan
2018 Breakfast with the Inspectors – Overview & Updates from the Inspectorate by Kimby Barton
2018 Breakfast with the Inspectors – Interactive Q&A Discussion Panel with Health Canada
2018 Breakfast with the Inspectors – Foreign Site Inspection Planning by Gita Nayeri
PSG Webinar – Become A Leader by Dr. Alireza Sharifi
PSG Webinar – Quality by Design (QbD) by James Pierce
PSG 2017 Health Canada Conference – CAPA Investigations (Raju Raghavan)
PSG 2017 Health Canada Conference – Best Practices to Consider When Filing – Plain Language Label (Veronica Yip)
PSG 2017 Health Canada Conference – Data Integrity and Out of Specification Investigations (Rosalee Scarito, Hons. BSc)
PSG 2017 Health Canada Conference – Post Notice of Compliance Changes (Krishnan Trirunella Ph.D)
PSG 2017 Health Canada Conference – Update on International Regulatory Collaborative Initiatives (Gary Condran)
PSG 2017 Health Canada Conference – Update to Health Canada’s Quality Guidance Documents for Pharmaceuticals (Alison Ingham, Ph.D)
PSG 2017 Health Canada Conference – Active Pharmaceutical Ingredients (Reza Salezadeh-Asl, MSc)
PSG 2017 Health Canada Conference – Foreign Site Inspections and Paper Assessments (Steven McCaul)
PSG 2017 Health Canada Conference – Health Products Inspections and Licensing (HPIL) Updates (Kimby Barton)
PSG 2017 Health Canada Conference – Update to Policies for Bioequivalence (Craig Simon, Ph.D)
PSG 2017 Health Canada Conference – Bureau of Pharmaceutical Science Priorities (Bruce Randall)
Essentials of Regulatory Affairs
Pharma Data Integrity
Changes at FDA
Good Documentation Practices in a GMP Environment
Understanding Biosimilars